Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study. - Bergh,J.; Wiklund,T.; Erikstein,B.; Lidbrink,E.; Lindman,H.; Malmström,P. (Lancet, 2000)